Urinary bladder wall mass with neoplastic lymphoid cells in the urine : Diagnosis of an IgG secretory B-cell lymphoma with Bence-Jones proteinuria in a dog

© 2022 American Society for Veterinary Clinical Pathology.

Bibliographische Detailangaben
Veröffentlicht in:Veterinary clinical pathology. - 1975. - 51(2022), 3 vom: 29. Sept., Seite 426-431
1. Verfasser: Jeffries, Christina (VerfasserIn)
Weitere Verfasser: Moore, A Russell, Schlemmer, Samantha N
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2022
Zugriff auf das übergeordnete Werk:Veterinary clinical pathology
Schlagworte:Case Reports Journal Article M-protein immunophenotyping protein electrophoresis urologic neoplasia Immunoglobulin G Bence Jones Protein 9006-99-9
LEADER 01000caa a22002652c 4500
001 NLM340169885
003 DE-627
005 20250303072801.0
007 cr uuu---uuuuu
008 231226s2022 xx |||||o 00| ||eng c
024 7 |a 10.1111/vcp.13102  |2 doi 
028 5 2 |a pubmed25n1133.xml 
035 |a (DE-627)NLM340169885 
035 |a (NLM)35488188 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Jeffries, Christina  |e verfasserin  |4 aut 
245 1 0 |a Urinary bladder wall mass with neoplastic lymphoid cells in the urine  |b Diagnosis of an IgG secretory B-cell lymphoma with Bence-Jones proteinuria in a dog 
264 1 |c 2022 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 14.09.2022 
500 |a Date Revised 14.09.2022 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a © 2022 American Society for Veterinary Clinical Pathology. 
520 |a In this study, we describe a multimodal approach to diagnose a unique case of myeloma-related disease, extranodal secretory B-cell lymphoma with urinary bladder involvement, an IgG4 monoclonal gammopathy, and Bence-Jones proteinuria in a dog with a 6-year history of hyperglobulinemia that had not been further evaluated. A 12-year-old dog was presented for evaluation of a 1-week history of tenesmus. Urine sediment cytologic evaluation revealed low to moderate numbers of intermediate to large-sized lymphocytes. We describe a technique that yielded adequate numbers of viable neoplastic cells in shipped urine sediment for PARR and flow cytometry. Those studies demonstrated a clonal immunoglobulin gene rearrangement and an expansion of CD21-positive and MHC Class II-negative B cells, respectively. Protein electrophoresis with immunofixation and proteomic evaluation revealed a serum and urine IgG4 monoclonal gammopathy with Bence-Jones proteinuria. MUM1 immunocytochemistry performed on the urine sediment slides failed to label the neoplastic cells; thus, a plasma cell tumor was considered unlikely. Lack of response to a cyclophosphamide, vincristine, and prednisone chemotherapy regimen led to euthanasia without necropsy 21 days after diagnosis. Lymphoma is the most common hematopoietic malignancy and accounts for up to a quarter of all neoplasms in dogs, but lymphoid neoplasms arising primarily from extranodal sites are infrequently reported. Urinary tract neoplasia can be diagnosed by urine evaluation in about one-third of canine cases, but the diagnosis of lymphoid neoplasia via urine evaluation is rarely reported. This case highlights the utility of ancillary diagnostics on urine for detection of lymphoid malignancies 
650 4 |a Case Reports 
650 4 |a Journal Article 
650 4 |a M-protein 
650 4 |a immunophenotyping 
650 4 |a protein electrophoresis 
650 4 |a urologic neoplasia 
650 7 |a Immunoglobulin G  |2 NLM 
650 7 |a Bence Jones Protein  |2 NLM 
650 7 |a 9006-99-9  |2 NLM 
700 1 |a Moore, A Russell  |e verfasserin  |4 aut 
700 1 |a Schlemmer, Samantha N  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Veterinary clinical pathology  |d 1975  |g 51(2022), 3 vom: 29. Sept., Seite 426-431  |w (DE-627)NLM098159984  |x 1939-165X  |7 nnas 
773 1 8 |g volume:51  |g year:2022  |g number:3  |g day:29  |g month:09  |g pages:426-431 
856 4 0 |u http://dx.doi.org/10.1111/vcp.13102  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 51  |j 2022  |e 3  |b 29  |c 09  |h 426-431